RE: RNS time8 Aug 2022 21:18
Tommy
you know this is absolute lies
""Makes you wonder why Astra Zeneca offered to pay 250m for a company that hasn’t brought anything to market in 20 years""
The truth
""The drugmaker (AZ)had hoped to develop the medicine for vulnerable patients with asthma and chronic lung disease, but it will now return rights to the product, known as AZD9412, to Synairgen.
Synairgen had licensed the drug to AstraZeneca in 2014 in a deal worth $232 million. Serious doubts about the product emerged in October 2016, however, when AstraZeneca stopped a mid-stage clinical study.
Again another trial FAILED...AZ did NOT try to pay SNG 250M - get it RIGHT! Otherwise mani will report you.......